case_images: PMC5602351_01
case_images: The tumor cells are arranged in broad, pushing, smooth-bordered islands abutted against a lymphocyte rich stroma and seen in 10x (Figure 1) and 20x (Figure 2).
case_images: fonc-07-00207-g001.jpg
case_images: PMC5602351_01_fonc-07-00207-g001.jpg
case_images: F1
case_images: The lobules of tumor were surrounded by lymphocytes and plasma cells (Figures 1 and 2).
case_images: Figure 1 magnification. The asterisks highlights the lobules of tumor in the images. These are surrounded by lymphocytes and plasma cells, as indicated by the arrow.
case_images: fonc-07-00207-g002.jpg
case_images: PMC5602351_01_fonc-07-00207-g002.jpg
case_images: F2
case_images: The lobules of tumor were surrounded by lymphocytes and plasma cells (Figures 1 and 2).
case_images: The neoplastic cells are strongly immunoreactive for pancytokeratin. Lymphocytes are negative.
case_images: fonc-07-00207-g003.jpg
case_images: PMC5602351_01_fonc-07-00207-g003.jpg
case_images: F3
case_images: The neoplastic cells were strongly immunoreactive for pancytokeratin and p63, as shown in Figures 3 and 4.
case_images: The tumor cell shows strong immunoreactivity to p63. Lymphocytes lack reactivity.
case_images: fonc-07-00207-g004.jpg
case_images: PMC5602351_01_fonc-07-00207-g004.jpg
case_images: F4
case_images: The neoplastic cells were strongly immunoreactive for pancytokeratin and p63, as shown in Figures 3 and 4.
case_images: Tumors cells that demonstrate strong positivity to CD5, also marking background lymphocytes.
case_images: fonc-07-00207-g005.jpg
case_images: PMC5602351_01_fonc-07-00207-g005.jpg
case_images: F5
case_images: T lymphocytes (Figure 5). The neoplastic cells were non-reactive with TTF1 and thyroglobulin.
case_images: Coronal section of radiotherapy plan showing 60 Gy dose line in green and boost volume in red.
case_images: fonc-07-00207-g006.jpg
case_images: PMC5602351_01_fonc-07-00207-g006.jpg
case_images: F6
case_images: A coronal section of the radiotherapy plan is shown in Figure 6.